StockClub

XERS

XERSXeris Biopharma Holdings, Inc.$ --
Xeris Biopharma Holdings, Inc.

Xeris Biopharma Holdings, Inc.

XERS

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
86M USD
YoY +42.8%
Operating Income
17M USD
YoY +899.0%
Net Income
11M USD
YoY +316.7%
EPS
0.07$
YoY +294.8%

Revenue

$291.8M
FY2024 Q1$40.6M
$40.6M
Q1
FY2024 Q2$88.7M
$88.7M
Q2
FY2024 Q3$143M
$143M
Q3
FY2024 Q4$203.1M
$203.1M
Q4
FY2025 Q1$60.1M
$60.1M
Q1
FY2025 Q2$131.7M
$131.7M
Q2
FY2025 Q3$206M
$206M
Q3
FY2025 Q4$291.8M
$291.8M
Q4
Actual
+$88.8M (+43.7%)

Net Income

$554,000
FY2024 Q1$-19M
$-19M
Q1
FY2024 Q2$-34M
$-34M
Q2
FY2024 Q3$-49.7M
$-49.7M
Q3
FY2024 Q4$-54.8M
$-54.8M
Q4
FY2025 Q1$-9.2M
$-9.2M
Q1
FY2025 Q2$-11.1M
$-11.1M
Q2
FY2025 Q3$-10.5M
$-10.5M
Q3
FY2025 Q4$554,000
$554,000
Q4
Actual
+$55.4M (+101.0%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$20.4M
Est:$22M
FY2020MISS
$20.4M
FY2021BEAT
Actual:$49.6M
Est:$47.5M
FY2021BEAT
$49.6M
FY2022BEAT
Actual:$110.2M
Est:$107.9M
FY2022BEAT
$110.2M
FY2023MISS
Actual:$163.9M
Est:$181.4M
FY2023MISS
$163.9M
FY2024BEAT
Actual:$203.1M
Est:$201.1M
FY2024BEAT
$203.1M
FY2025BEAT
Actual:$291.8M
Est:$288.2M
FY2025BEAT
$291.8M

Analyst Estimates